Overview A Study of TRK-170 for the Treatment of Crohn's Disease Status: Completed Trial end date: 2014-04-01 Target enrollment: Participant gender: Summary In Crohn's Disease Patients - To evaluate the efficacy of TRK-170 - To evaluate the PK characteristics of TRK-170 - To assess the safety of TRK-170 Phase: Phase 2 Details Lead Sponsor: Toray Industries, Inc